Growth Metrics

Novartis Ag (NVS) Divestments (2016 - 2025)

Novartis Ag's Divestments history spans 13 years, with the latest figure at -$2.2 billion for Q2 2025.

  • On a quarterly basis, Divestments rose 30.06% to -$2.2 billion in Q2 2025 year-over-year; TTM through Jun 2025 was -$6.0 billion, a 19.14% decrease, with the full-year FY2025 number at -$88.0 million, down 182.24% from a year prior.
  • Divestments hit -$2.2 billion in Q2 2025 for Novartis Ag, down from $330.0 million in the prior quarter.
  • Over the last five years, Divestments for NVS hit a ceiling of $877.0 million in Q4 2021 and a floor of -$11.6 billion in Q2 2022.
  • Historically, Divestments has averaged -$1.2 billion across 5 years, with a median of -$111.0 million in 2022.
  • Biggest five-year swings in Divestments: surged 43950.0% in 2021 and later tumbled 12087.63% in 2022.
  • Tracing NVS's Divestments over 5 years: stood at $877.0 million in 2021, then crashed by 116.88% to -$148.0 million in 2022, then tumbled by 398.65% to -$738.0 million in 2023, then crashed by 334.55% to -$3.2 billion in 2024, then skyrocketed by 30.06% to -$2.2 billion in 2025.
  • Business Quant data shows Divestments for NVS at -$2.2 billion in Q2 2025, $330.0 million in Q1 2025, and -$3.2 billion in Q2 2024.